drugset / Trial / NCT01086436

Study to Evaluate the Safety of Rotarix™ in Chinese Children

NCT01086436

Phase 1 Completed 50 enrolled GlaxoSmithKline
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to assess the safety of Rotarix ™ when administered in healthy children aged 2 to 6 years in China.

Timeline

Start
2010-03-13
Primary completion
2010-04-16
Completion
2010-04-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Rotarix Vaccine Oral

Indications